Prostate Cancer Flashcards
Epidemiology
Prostate
Most common cancer in males.
65 years and older.
African American.
Prognostic factors
Prostate
Stage
Grade
PSA level
LN status
LN drainage
Prostate
Periprostatic and obturaror External iliac Internal iliac Common iliac Periaortic
Clin. Pres.
Prostate
Decreased urinary stream Frequency Difficulty starting urination Dysuria Hematuria
When should PSA and DRE
screening start
Prostate
Older than 50
Normal PSA level
< 4 ng/ml
Pathology
Prostate
Adenocarcinoma
Observation as tmt for
Prostate
Older than 75.
65-75 with small well-differentiated.
Tmt for T1 or T2
Prostate
Prostatectomy
Tmt for T3
Prostate
EBRT with hormone therapy
Hormone therapy options
Prostate
Orchiectomy
Estrogen
Gonadotropin-releasing hormone agonists (Zoladex, Lupron).
Nonsteroidal antiandrogens (Eulexin, Casodex).
Metastatic pt Tmt
Prostate
Docetaxel plus prednisone when HT is no longer effective.
Dose to pelvic LN
Prostate
45-50Gy
Dose to seminal vesicles
54-56Gy
Dose to prostate
72-80Gy (1.8-2Gy/day)